메뉴 건너뛰기




Volumn 332, Issue 3, 2006, Pages 142-147

Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor

Author keywords

FGF23; Hypophosphatemia; Mesenchymal tumor; Oncogenic osteomalacia

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; MEDRONATE TECHNETIUM TC 99M; PHOSPHATE;

EID: 33748742433     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200609000-00010     Document Type: Article
Times cited : (22)

References (27)
  • 1
    • 9144231813 scopus 로고    scopus 로고
    • Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: An analysis of 32 cases and a comprehensive review of the literature
    • Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia- associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 2004;28:1-30.
    • (2004) Am J Surg Pathol , vol.28 , pp. 1-30
    • Folpe, A.L.1    Fanburg-Smith, J.C.2    Billings, S.D.3
  • 3
    • 0031780399 scopus 로고    scopus 로고
    • Oncogenic osteomalacia: Case report and review of head and neck associated tumours
    • Gonzalez-Compta X, Mañós-Pujol M, Foglia-Fernandez M, et al. Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol 1998;112:389-92.
    • (1998) J Laryngol Otol , vol.112 , pp. 389-392
    • Gonzalez-Compta, X.1    Mañós-Pujol, M.2    Foglia-Fernandez, M.3
  • 4
    • 0023118664 scopus 로고
    • Phosphaturic mesenchymal tumors: A polymorphous group causing osteomalacia or rickets
    • Weidner N, Cruz DS. Phosphaturic mesenchymal tumors: a polymorphous group causing osteomalacia or rickets. Cancer 1987;59:1442-54.
    • (1987) Cancer , vol.59 , pp. 1442-1454
    • Weidner, N.1    Cruz, D.S.2
  • 5
    • 0028363099 scopus 로고
    • Tumor-induced osteomalacia: Unveiling a new hormone
    • Econs MJ, Drezner MK. Tumor-induced osteomalacia: unveiling a new hormone. N Engl J Med 1994;330:1679-81.
    • (1994) N Engl J Med , vol.330 , pp. 1679-1681
    • Econs, M.J.1    Drezner, M.K.2
  • 6
    • 14344279878 scopus 로고    scopus 로고
    • Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
    • Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001;98:6500-6505.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 6500-6505
    • Shimada, T.1    Mizutani, S.2    Muto, T.3
  • 7
    • 0033763097 scopus 로고    scopus 로고
    • Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23
    • White KE, Evans WE, O'Riordan JL, et al. Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 2000;26:345-8.
    • (2000) Nat Genet , vol.26 , pp. 345-348
    • White, K.E.1    Evans, W.E.2    O'Riordan, J.L.3
  • 8
    • 18744371012 scopus 로고    scopus 로고
    • Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
    • Yamazaki Y, Okazaki R, Shibata M, et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002;87:4957-60.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 4957-4960
    • Yamazaki, Y.1    Okazaki, R.2    Shibata, M.3
  • 9
    • 20844452698 scopus 로고    scopus 로고
    • Role of fibroblast growth factor 23 in health and chronic kidney disease
    • Fukagawa M, Nii-Kono T, Kazama JJ. Role of fibroblast growth factor 23 in health and chronic kidney disease. Curr Opin Nephrol Hypertens 2005;14:325-9.
    • (2005) Curr Opin Nephrol Hypertens , vol.14 , pp. 325-329
    • Fukagawa, M.1    Nii-Kono, T.2    Kazama, J.J.3
  • 10
    • 0141844575 scopus 로고    scopus 로고
    • Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
    • Liu S, Guo R, Simpson LG, et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 2003;278:37419-26.
    • (2003) J Biol Chem , vol.278 , pp. 37419-37426
    • Liu, S.1    Guo, R.2    Simpson, L.G.3
  • 11
    • 0037295477 scopus 로고    scopus 로고
    • Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia
    • Larsson T, Zahradnik R, Lavigne J, et al. Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia. Eur J Endocrinol 2003;148:269-76.
    • (2003) Eur J Endocrinol , vol.148 , pp. 269-276
    • Larsson, T.1    Zahradnik, R.2    Lavigne, J.3
  • 12
    • 0141453087 scopus 로고    scopus 로고
    • Fibroblast growth factor 23: A new clinical marker for oncogenic osteomalacia
    • Nelson AE, Bligh RC, Mirams M, et al. Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab 2003;88:4088-94.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 4088-4094
    • Nelson, A.E.1    Bligh, R.C.2    Mirams, M.3
  • 13
    • 0038311933 scopus 로고    scopus 로고
    • Regulation of Na/Pi transporter in the proximal tubule
    • Murer H, Hernando N, Foster I, et al. Regulation of Na/Pi transporter in the proximal tubule. Annu Rev Physiol 2003;65:531-42.
    • (2003) Annu Rev Physiol , vol.65 , pp. 531-542
    • Murer, H.1    Hernando, N.2    Foster, I.3
  • 14
    • 2142746439 scopus 로고    scopus 로고
    • FGF23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
    • Shimada T, Hasegawa H, Yamazaki Y, et al. FGF23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004;19:429-35.
    • (2004) J Bone Miner Res , vol.19 , pp. 429-435
    • Shimada, T.1    Hasegawa, H.2    Yamazaki, Y.3
  • 16
    • 4043052503 scopus 로고    scopus 로고
    • Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia
    • Takeuchi Y, Suzuki H, Ogura S, et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 2004;89:3979-82.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 3979-3982
    • Takeuchi, Y.1    Suzuki, H.2    Ogura, S.3
  • 17
    • 84957412176 scopus 로고
    • Osteomalacia with Loosers nodes (Milkmans syndrome) due to the raised resistance to vitamin D acquired about the age of 15 years
    • McCance RA. Osteomalacia with Loosers nodes (Milkmans syndrome) due to the raised resistance to vitamin D acquired about the age of 15 years. Q J Med 1947;16:33-47.
    • (1947) Q J Med , vol.16 , pp. 33-47
    • McCance, R.A.1
  • 19
    • 0031035615 scopus 로고    scopus 로고
    • Autosomal dominant hypophosphatemic rickets/osteomalacia: Clinical characterization of a novel renal phosphate-wasting disorder
    • Econs ML, McEnery PT. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 1997;82:674-81.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 674-681
    • Econs, M.L.1    McEnery, P.T.2
  • 20
    • 14944360740 scopus 로고    scopus 로고
    • Octreotide therapy for tumor-induced osteomalacia
    • Seufert J, Ebert K, Müller J, et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 2001;345:1883-8.
    • (2001) N Engl J Med , vol.345 , pp. 1883-1888
    • Seufert, J.1    Ebert, K.2    Müller, J.3
  • 21
    • 0035725603 scopus 로고    scopus 로고
    • Oncogenic osteomalacia associated with mesenchymal tumor detected by indium-111 octreotide scintigraphy
    • Oxf
    • Rhee Y, Lee JD, Shin KH, et al. Oncogenic osteomalacia associated with mesenchymal tumor detected by indium-111 octreotide scintigraphy. Clin Endocrinol (Oxf) 2001;54:551-4.
    • (2001) Clin Endocrinol , vol.54 , pp. 551-554
    • Rhee, Y.1    Lee, J.D.2    Shin, K.H.3
  • 22
    • 0032916730 scopus 로고    scopus 로고
    • Indium-111 pentreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia
    • Nguyen BD, Wang EA. Indium-111 pentreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia. Clin Nucl Med 1999;24:130-31.
    • (1999) Clin Nucl Med , vol.24 , pp. 130-131
    • Nguyen, B.D.1    Wang, E.A.2
  • 23
    • 0037006672 scopus 로고    scopus 로고
    • Localization of mesenchymal tumours by somatostatin receptor imaging
    • Jan de Beur SM, Streeten EA, Civelek AC, et al. Localization of mesenchymal tumours by somatostatin receptor imaging. Lancet 2002;359:761-3.
    • (2002) Lancet , vol.359 , pp. 761-763
    • Jan De Beur, S.M.1    Streeten, E.A.2    Civelek, A.C.3
  • 24
    • 15544385175 scopus 로고    scopus 로고
    • Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case
    • Dupond JL, Mahammedi H, Prié D, et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case. Bone 2005;36:375-8.
    • (2005) Bone , vol.36 , pp. 375-378
    • Dupond, J.L.1    Mahammedi, H.2    Prié, D.3
  • 25
    • 0022532860 scopus 로고
    • Studies in a patient with tumor-induced hypophosphatemic osteomalacia
    • Ryan WG, Gitelis S, Charters JR. Studies in a patient with tumor-induced hypophosphatemic osteomalacia. Calcif Tissue Int 1986;38:358-62.
    • (1986) Calcif Tissue Int , vol.38 , pp. 358-362
    • Ryan, W.G.1    Gitelis, S.2    Charters, J.R.3
  • 26
    • 0030632208 scopus 로고    scopus 로고
    • Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: A case report
    • Yang IM, Park YK, Hyun YJ, et al. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report. Korean J Intern Med 1997;12:89-95.
    • (1997) Korean J Intern Med , vol.12 , pp. 89-95
    • Yang, I.M.1    Park, Y.K.2    Hyun, Y.J.3
  • 27
    • 3242661165 scopus 로고    scopus 로고
    • Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency
    • Shigematsu T, Kazama JJ, Yamashita T, et al. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 2004;44:250-6.
    • (2004) Am J Kidney Dis , vol.44 , pp. 250-256
    • Shigematsu, T.1    Kazama, J.J.2    Yamashita, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.